Rockville, MD, USA, Aug. 16, 2017 -- The Regulatory Affairs Professionals Society (RAPS) has published the updated, 10th edition of Fundamentals of US Regulatory Affairs, the most extensive reference available on regulatory affairs for pharmaceuticals, medical devices, biologics and other healthcare products intended for the US market. The book is an essential reference for anyone responsible for products that must comply with regulations from the US Food and Drug Administration (FDA) and other relevant US agencies.
|
||||||||
The first edition of US Fundamentals was introduced two decades ago and has undergone regular revisions over the years, reflecting changing regulations and new technologies. Fundamentals of US Regulatory Affairs, 10th Edition has been completely updated with information that is current as of May 2017. Notable changes from the previous edition include more detail in areas such as preclinical trials and Good Laboratory Practices, and clinical trials and Good Clinical Practices. New chapters have been added on traceability and supply chain, and biosimilars. In all, the book is comprised of 44 chapters by 53 regulatory experts.
In addition, for the first time, RAPS has also published two sector-specific US fundamentals books, Fundamentals of US Medical Device Regulations and Fundamentals of US Pharmaceutical & Biologics Regulations. Each one presents the same content published in the 10th edition, but only that which is related to either medical devices or pharmaceuticals and biologics, respectively. This allows those who work exclusively in one sector or the other to get all the information that is pertinent to them without additional content that may not be.
The list price for the full 10th edition is $395, while RAPS members get $100 off that price. Each of the sector-specific books is available for $225 list, and $175 for members. All are available in both print and e-book versions.
Since its introduction, US Fundamentals has sold more than 30,000 copies. It is relied upon by regulatory and legal professionals, professors, students, career-changers and FDA staffers as a valued reference, academic textbook and Regulatory Affairs Certification (RAC) study tool.
For more information or to order any of the fundamentals books, visit RAPS.org/fundamentals.
About RAPS
The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. RAPS offers education and training, professional standards, publications, research, knowledge sharing, networking, career development opportunities and other valuable resources, including Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. RAPS is headquartered in suburban Washington, DC, with chapters and affiliates worldwide. www.RAPS.org
###
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/f42a58a7-9328-488d-ba2f-3b0eb765e033
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/14d84e82-492a-4d4d-8719-c14b97005013
Zachary Brousseau Regulatory Affairs Professionals Society (RAPS) 301 770 2920, ext. 245 [email protected]


Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
Bill Ackman Eyes New Fund to Bet Against Market Complacency
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb 



